Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2021 Earnings Conference Call November 4, 2021 8:00 AM ET Company Participants Juli Miller - IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer John Lunger - Chief Patient Supply Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Conference Call Participants Marc Frahm - Cowen & Company Michael Schmidt - Guggenheim Nick Abbott - Wells Fargo Mara Goldstein - Mizuho Operator Good day, and thank you for standing by. Welcom ...